|
1.
|
J XuQ LiReview of the in vivo functions of
the p160 steroid receptor coactivator familyMol
Endocrinol1716811692200310.1210/me.2003-011612805412
|
|
2.
|
SL AnzickJ KononenRL WalkerDO AzorsaMM
TannerXY GuanG SauterOP KallioniemiJM TrentPS MeltzerAIB1, a
steroid receptor coactivator amplified in breast and ovarian
cancerScience277965968199710.1126/science.277.5328.9659252329
|
|
3.
|
MI Torres-ArzayusJ Font de MoraJ YuanF
VazquezR BronsonM RueWR SellersM BrownHigh tumor incidence and
activation of the PI3K/AKT pathway in transgenic mice define AIB1
as an oncogeneCancer
Cell6263274200410.1016/j.ccr.2004.06.02715380517
|
|
4.
|
SQ KuangL LiaoH ZhangAV LeeBW O'MalleyJ
XuAIB1/SRC-3 deficiency affects insulin-like growth factor 1
signaling pathway and suppresses v-Ha-ras-induced breast cancer
initiation and progression in miceCancer
Res6418751885200410.1158/0008-5472.CAN-03-374514996752
|
|
5.
|
SQ KuangL LiaoS WangD MedinaBW O'MalleyJ
XuMice lacking the amplified in breast cancer 1/steroid receptor
coactivator-3 are resistant to chemical carcinogen-induced mammary
tumorigenesisCancer Res6579938002200516140972
|
|
6.
|
A CosteMC AntalS ChanP KastnerM MarkBW
O'MalleyJ AuwerxAbsence of the steroid receptor coactivator-3
induces B-cell lymphomaEMBO
J2524532464200610.1038/sj.emboj.760110616675958
|
|
7.
|
G MaY RenK WangJ HeSRC-3 has a role in
cancer other than as a nuclear receptor coactivatorInt J Biol
Sci7664672201110.7150/ijbs.7.66421647249
|
|
8.
|
S WerbajhI NojekR LanzMA CostasRAC-3 is a
NF-kappa B coactivatorFEBS
Lett485195199200010.1016/S0014-5793(00)02223-711094166
|
|
9.
|
MC LouieJX ZouA RabinovichHW ChenACTR/AIB1
functions as an E2F1 coactivator to promote breast cancer cell
proliferation and antiestrogen resistanceMol Cell
Biol2451575171200410.1128/MCB.24.12.5157-5171.200415169882
|
|
10.
|
H YamashitaS TakahashiY ItoT YamashitaY
AndoT ToyamaH SugiuraN YoshimotoS KobayashiY FujiiH IwasePredictors
of response to exemestane as primary endocrine therapy in estrogen
receptor-positive breast cancerCancer
Sci10020282033200910.1111/j.1349-7006.2009.01274.x19659610
|
|
11.
|
L LiaoSQ KuangY YuanSM GonzalezBW
O'MalleyJ XuMolecular structure and biological function of the
cancer-amplified nuclear receptor coactivator SRC-3/AIB1J Steroid
Biochem Mol Bio83314200210.1016/S0960-0760(02)00254-612650696
|
|
12.
|
J YanSY TsaiMJ TsaiSRC-3/AIB1:
transcriptional coactivator in oncogenesisActa Pharmacol
Sin27387394200610.1111/j.1745-7254.2006.00315.x16539836
|
|
13.
|
L AmazitL PasiniAT SzafranV BernoRC WuM
MielkeED JonesMG ManciniCA HinojosBW O'MalleyMA ManciniRegulation
of SRC-3 intercompartmental dynamics by estrogen receptor and
phosphorylationMol Cell
Biol2769136932200710.1128/MCB.01695-0617646391
|
|
14.
|
T LahusenRT HenkeBL KaganA WellsteinAT
RiegelThe role and regulation of the nuclear receptor co-activator
AIB1 in breast cancerBreast Cancer Res
Treat116225237200910.1007/s10549-009-0405-219418218
|
|
15.
|
J XuRC WuBW O'MalleyNormal and
cancer-related functions of the p160 steroid receptor co-activator
(SRC) familyNat Rev Cancer9615630200910.1038/nrc269519701241
|
|
16.
|
O GojisB RudrarajuC AlifrangisJ KrellP
LibalovaC PalmieriThe role of steroid receptor coactivator-3
(SRC-3) in human malignant diseaseEur J Surg
Oncol36224229201010.1016/j.ejso.2009.08.00219716257
|
|
17.
|
O GojisB RudrarajuM GudiK HogbenS SoushaRC
CoombesS CleatorC PalmieriThe role of SRC-3 in human breast
cancerNat Rev Clin
Oncol78389201010.1038/nrclinonc.2009.21920027190
|
|
18.
|
JP LydonBW O'MalleyMinireview: steroid
receptor coactivator-3: a multifarious coregulator in mammary gland
metastasisEndocrinology1521925201110.1210/en.2010-101221047941
|
|
19.
|
AB JohnsonBW O'MalleySteroid receptor
coactivators 1, 2, and 3: critical regulators of nuclear receptor
activity and steroid receptor modulator (SRM)-based cancer
therapyMol Cel
Endocrinol348430439201210.1016/j.mce.2011.04.02121664237
|
|
20.
|
RS SavkurTP BurrisThe coactivator LXXLL
nuclear receptor recognition motifJ Pept
Res63207212200410.1111/j.1399-3011.2004.00126.x15049832
|
|
21.
|
H ChenRJ LinRL SchilzD ChakravartiA NashL
NagyML PrivalskyY NakataniRM EvansNuclear receptor coactivator ACTR
is a novel histone acetyltransferase and forms a multimeric
activation complex with p/CAF and
CBP/300Cell90569580199710.1016/S0092-8674(00)80516-49267036
|
|
22.
|
JJ VoegelMJ HeineM TiniV VivatP ChambonH
GronemeyerThe coactivator TIF2 contains three nuclear
receptor-binding motifs and mediates transactivation through CBP
binding-dependent and -independent pathwaysEMBO
J17507519199810.1093/emboj/17.2.507
|
|
23.
|
J LiBW O'MalleyJ Wongp300 requires its
histone acetyltransferase activity and SRC-1 interaction domain to
facilitate thyroid hormone receptor activation in chromatinMol Cell
Biol2020312042200010.1128/MCB.20.6.2031-2042.2000
|
|
24.
|
C QiJ ChangY ZhuAV YeldandiSM RaoYJ
ZhuIdentification of protein arginine methyltransferase 2 as a
coactivator for estrogen receptor alphaJ Biol
Chem2772862428630200210.1074/jbc.M20105320012039952
|
|
25.
|
C TeyssierD ChenMR StallcupRequirement for
multiple domains of the protein arginine methyltransferase CARM1 in
its transcriptional coactivator functionJ Biol
Chem2774606646072200210.1074/jbc.M20762320012351636
|
|
26.
|
DY LeeC TeyssierBD StrahlMR StallcupRole
of protein methylation in regulation of transcriptionEndocr
Rev26147170200510.1210/er.2004-000815479858
|
|
27.
|
TE SpencerG JensterMM BurcinCD AllisJ
ZhouCA MizzenNJ McKennaSA OnateSY TsaiMJ TsaiBW O'MalleySteroid
receptor coactivator-1 is a histone acetyl
transferaseNature389194198199710.1038/383049296499
|
|
28.
|
D ChenH MaH HongSS KohSM HuangBT
SchurterDW AswadMR StallcupRegulation of transcription by a protein
methyltransferaseScience28421742177199910.1126/science.284.5423.217410381882
|
|
29.
|
SS KohD ChenYH LeeMR StallcupSynergistic
enhancement of nuclear receptor function by p160 coactivators and
two coactivators with protein methyltransferase activitiesJ Biol
Chem27610891098200110.1074/jbc.M00422820011050077
|
|
30.
|
RC WuCL SmithBW O'MalleyTranscriptional
regulation by steroid receptor coactivator phosphorylationEndocr
Rev26393399200510.1210/er.2004-001815814849
|
|
31.
|
AS OhJT LahusenCD ChienMP FereshtehX
ZhangS DakshanamurthyJ XuBL KaganA WellsteinAT RiegelTyrosine
phosphorylation of the nuclear receptor coactivator AIB1/SRC-3 is
enhanced by Abl kinase and is required for its activity in cancer
cellsMol Cell Biol2865806593200810.1128/MCB.00118-0818765637
|
|
32.
|
C LiYY LiangXH FengSY TsaiMJ TsaiBW
O'MalleyEssential phosphatases and a phospho-degron are critical
for regulation of SRC-3/AIB1 coactivator function and turnoverMol
Cell31835849200810.1016/j.molcel.2008.07.01918922467
|
|
33.
|
P YiQ FengL AmazitDM LonardSY TsaiMJ
TsaiBW O'MalleyAtypical protein kinase C regulates dual pathways
for degradation of the oncogenic coactivator SRC-3/AIB1Mol
Cell29465476200810.1016/j.molcel.2007.12.03018313384
|
|
34.
|
C LiJ AoJ FuDF LeeJ XuD LonardBW
O'MalleyTumor-suppressor role for the SPOP ubiquitin ligase in
signal-dependent proteolysis of the oncogenic co-activator
SRC-3/AIB1Oncogene3043504364201110.1038/onc.2011.15121577200
|
|
35.
|
H WuL SunY ZhangY ChenB ShiR LiY WangJ
LiangD FanG WuCoordinated regulation of AIB1 transcriptional
activity by sumolylation and phosphorylationJ Biol
Chem2812184821856200610.1074/jbc.M60377220016760465
|
|
36.
|
S LiC YangY HongH BiF ZhaoY LiuX AoP PangX
XingAK ChangThe transcriptional activity of co-activator AIB1 is
regulated by the SUMO E3 Ligase PIAS1Biol
Cell104287296201210.1111/boc.20110011622283414
|
|
37.
|
P LabhartS KarmakarEM SalicruBS EganV
AlexiadisBW O'MalleyCL SmithIdentification of target genes in
breast cancer cells directly regulated by the SRC-3/AIB1
coactivatorProc Natl Acad Sci
USA10213391344200510.1073/pnas.040957810215677324
|
|
38.
|
S LiY ShangRegulation of SRC family
coactivators by post-translational modificationsCell
Signal1911011112200710.1016/j.cellsig.2007.02.00217368849
|
|
39.
|
S BautistaH VallèsRL WalkerS AnzickR
ZeillingerP MeltzerC TheilletIn breast cancer, amplification of the
steroid receptor coactivator gene AIB1 is correlated with estrogen
and progesterone receptor positivityClin Cancer
Res42925292919989865902
|
|
40.
|
M GlaeserT FloetottoB HansteinMW BeckmannD
NiederacherGene amplification and expression of the steroid
receptor coactivator SRC3 (AIB1) in sporadic breast and endometrial
carcinomasHorm Metab
Res33121126200110.1055/s-2001-1493811355743
|
|
41.
|
HJ ListR ReiterB SinghA WellsteinAT
RiegelExpression of the nuclear coactivator AIB1 in normal and
malignant breast tissueBreast Cancer Res
Treat682128200110.1023/A:101791092439011678305
|
|
42.
|
C ZhaoK YasuiCJ LeeH KuriokaY HosokawaT
OkaJ InazawaElevated expression levels of NCOA3, TOP1, and TFAP2C
in breast tumors as predictors of poor
prognosisCancer981823200310.1002/cncr.1148212833450
|
|
43.
|
L QinL LiaoA RedmondL YoungY YuanH ChenBW
O'MalleyJ XuThe AIB1 oncogene promotes breast cancer metastasis by
activation of PEA3-mediated matrix metallopteinase 2 (MMP2) and
MMP9 expressionMol Cell
Biol2859375950200810.1128/MCB.00579-0818644862
|
|
44.
|
T KirkegaardLM McGlynnFM CampbellS
MüllerSM ToveyB DunneKV NielsenTG CookeJM BartlettAmplified in
breast cancer 1 in human epidermal growth factor receptor-positive
tumors of tamoxifen-treated breast cancer patientsClin Cancer
Res1314051411200710.1158/1078-0432.CCR-06-1933
|
|
45.
|
T BourasMC SoutheyDJ VenterOverexpression
of the steroid receptor coactivator AIB1 in breast cancer
correlates with the absence of estrogen and progesterone receptors
and positivity for p53 and HER2/neuCancer
Res61903907200111221879
|
|
46.
|
K LeeA LeeBJ SongCS KangExpression of AIB1
protein as a prognostic factor in breast cancerWorld J Sur
Oncol9139201110.1186/1477-7819-9-13922035181
|
|
47.
|
VJ GnanapragasamHY LeungAS PulimoodDE
NealCN RobsonExpression of RAC 3, a steroid hormone receptor
co-activator in prostate cancerBr J
Cancer8519281936200110.1054/bjoc.2001.217911747336
|
|
48.
|
T BarkhemS NilssonJA GustafssonMolecular
mechanisms, physiological consequences and pharmacological
implications of estrogen receptor actionAm J
Pharmacogenomics41928200410.2165/00129785-200404010-00003
|
|
49.
|
HJ ListKJ LauritsenR ReiterC PowersA
WellsteinAT RiegelRibozyme targeting demonstrates that the nuclear
receptor coactivator AIB1 is a rate-limiting factor for
estrogen-dependent growth of human MCF-7 breast cancer cellsJ Biol
Chem2762376323768200110.1074/jbc.M102397200
|
|
50.
|
S KarmakarEA FosterCL SmithUnique roles of
p160 coactivators for regulation of breast cancer cell
proliferation and estrogen receptor-alpha transcriptional
activityEndocrinology15015881596200910.1210/en.2008-1001
|
|
51.
|
S KarmakarT GaoMC PaceS OesterreichCL
SmithCooperative activation of cyclin D1 and progesterone receptor
gene expression by the SRC-3 coactivator and SMRT corepressorMol
Endocrinol2411871202201010.1210/me.2009-048020392877
|
|
52.
|
MP FereshtehMT TilliSE KimJ XuBW O'MalleyA
WellsteinPA FurthAT RiegelThe nuclear receptor coactivator
amplified in breast cancer-1 is required for Neu (ErbB2/HER2)
activation, signaling, and mammary tumorigenesis in miceCancer
Res6836973706200810.1158/0008-5472.CAN-07-670218483252
|
|
53.
|
S AlknerPO BendahlD GrabauK LövgrenO StålL
RydénM FernöSwedish and South-East Swedish Breast Cancer GroupsAIB1
is a predictive factor for tamoxifen response in premenopausal
womenAnn Oncol21238244201010.1093/annonc/mdp29319628566
|
|
54.
|
Q SuS HuH GaoR MaQ YangZ PanT WangF LiRole
of AIB1 for tamoxifen resistance in estrogen receptor-positive
breast cancer
cellsOncology75159168200810.1159/00015926718827493
|
|
55.
|
S MassarwehCK OsborneCJ CreightonL QinA
TsimelzonS HuangH WeissM RimawiR SchiffTamoxifen resistance in
breast tumors is driven by growth factor receptor signaling with
repression of classic estrogen receptor genomic functionCancer
Res68826833200810.1158/0008-5472.CAN-07-270718245484
|
|
56.
|
S KarmakarEA FosterJK BlackmoreCL
SmithDistinctive functions of p160 steroid receptor coactivators in
proliferation of an estrogen-independent, tamoxifen-resistant
breast cancer cell lineEndocr Relat
Cancer18113127201110.1677/ERC-09-028521059860
|
|
57.
|
CK OsborneJ ShouS MassarwehR
SchiffCrosstalk between estrogen receptor and growth factor
receptor pathways as a cause for endocrine therapy resistance in
breast cancerClin Cancer Res11865s870s200515701879
|
|
58.
|
G ArpinoL WiechmannCK OsborneR
SchiffCrosstalk between the estrogen receptor and the HER tyrosine
kinase receptor family: molecular mechanism and clinical
implications for endocrine therapy resistanceEndocr
Rev29217233200810.1210/er.2006-0045
|
|
59.
|
R ReiterAS OhA WellsteinAT RiegelImpact of
the nuclear receptor coactivator AIB1 isoform AIB1-Delta3 on
estrogenic ligands with different intrinsic
activityOncogene23403409200410.1038/sj.onc.120720214691461
|
|
60.
|
RB LanzY BulynkoA MalovannayaP LabhartL
WangW LiJ QinM HarperBW O'MalleyGlobal characterization of
transcriptional impact of the SRC-3 coregulatorMol
Endocrinol24859872201010.1210/me.2009-049920181721
|
|
61.
|
MI Torres-ArzayusJ ZhaoR BronsonM
BrownEstrogen-dependent and estrogen-independent mechanisms
contribute to AIB1-mediated tumor formationCancer
Res7041024111201010.1158/0008-5472.CAN-09-408020442283
|
|
62.
|
CM SilvaMA ShupnikIntegration of steroid
and growth factor pathways in breast cancer: focus on signal
transducers and activators of transcription and their potential
role in resistanceMol
Endocrinol2114991512200710.1210/me.2007-010917456797
|
|
63.
|
A OhHJ ListR ReiterA ManiY ZhangE GehanA
WellsteinAT RiegelThe nuclear receptor coactivator AIB1 mediates
insulin-like growth factor I-induced phenotypic changes in human
breast cancer cellsCancer
Res6482998308200410.1158/0008-5472.CAN-04-035415548698
|
|
64.
|
J YanCT YuM OzenM IttmannSY TsaiMJ
TsaiSteroid receptor coactivator-3 and activator protein-1
coordinately regulate the transcription of components of the
insulin-like growth factor/AKT signaling pathwayCancer
Res661103911046200610.1158/0008-5472.CAN-06-244217108143
|
|
65.
|
L LiaoX ChenS WangAF ParlowJ XuSteroid
receptor coactivator 3 maintains circulating insulin-like growth
factor (IGF-I) by controlling IGF-binding protein 3 expressionMol
Cell Biol2824602469200810.1128/MCB.01163-0718212051
|
|
66.
|
MI Torres-ArzayusJ YuanJL DellaGattaH
LaneAL KungM BrownTargeting the AIB1 oncogene through mammalian
target of rapamycin inhibition in the mammary glandCancer
Res661138111388200610.1158/0008-5472.CAN-06-231617145884
|
|
67.
|
KM HardyBW BoothMJ HendrixDS SalomonL
StrizziErbB/EGF signaling and EMT in mammary development and breast
cancerJ Mammary Gland Biol
Neoplasia15191199201010.1007/s10911-010-9172-220369376
|
|
68.
|
T LahusenM FereshtehA OhA WellsteinAT
RiegelEpidermal growth factor receptor tyrosine phosphorylation and
signaling controlled by a nuclear receptor coactivator, amplified
in breast cancer 1Cancer
Res6772567265200710.1158/0008-5472.CAN-07-1013
|
|
69.
|
W LongP YiL AmazitHL LaMarcaF AshcroftR
KumarMA ManciniSY TsaiMJ TsaiBW O'MalleySRC-3Delta4 mediates the
interaction of EGFR with FAK to promote cell migrationMol
Cell37321332201010.1016/j.molcel.2010.01.00420159552
|
|
70.
|
GP ColoRR RosatoS GrantMA CostasRAC3
down-regulation sensitizes human chronic myeloid leukemia cells to
TRAIL-induced apoptosisFEBS
Lett58150755081200710.1016/j.febslet.2007.09.05217927986
|
|
71.
|
GP ColoMF RubioIM NojekSE WerbajhPC
EcheverríaCV AlvaradoVE NahmodMD GalignianaMA CostasThe p160
nuclear receptor co-activator RAC3 exerts an anti-apoptotic role
through a cytoplasmatic
actionOncogene2724302444200810.1038/sj.onc.121090017968310
|
|
72.
|
J FerragudA Avivar-ValderasA PlaJ De Las
RivasJF de MoraTranscriptional repression of the tumor suppressor
DRO1 by AIB1FEBS
Lett58530413046201110.1016/j.febslet.2011.08.02521871888
|
|
73.
|
K AokiYJ SunS AokiK WadaE WadaCloning,
expression, and mapping of a gene that is upregulated in adipose
tissue of mice deficient in bombesin receptor subtype-3Biochem
Biophys Res Commun29012821288200210.1006/bbrc.2002.633711812002
|
|
74.
|
GT BommerC JägerEM DürrS BaehsST
EichhorstT BrabletzG HuT FröhlichG ArnoldDC KressDRO1, a gene
down-regulated by oncogenes, mediates growth inhibition in colon
and pancreatic cancer cellsJ Biol
Chem28079627975200510.1074/jbc.M41259320015563452
|
|
75.
|
F TremblayT RevettC HuardY ZhangJF TobinRV
MartinezRE GimenoBidirectional modulation of adipogenesis by the
secreted protein Ccdc80/DRO1/URBJ Biol
Chem28481368147200910.1074/jbc.M80953520019141617
|
|
76.
|
D CorkeryG ThillainadesanN CoughlanRD
MohanM IsovicM TiniJ TorchiaRegulation of the BRCA1 gene by an
SRC3/53BP1 complexBMC
Biochem1250201110.1186/1471-2091-12-5021914189
|
|
77.
|
CK OsborneR SchiffMechanisms of endocrine
resistance in breast cancerAnnu Rev
Med62233247201110.1146/annurev-med-070909-18291720887199
|
